手法を比較

	服薬レジメン複雑性指数（MRCI）	治療満足度質問票（TSQM）
分野	薬理学	薬理学
系統	Process / pipeline	Process / pipeline
提唱年	2012	2004
提唱者	Morgado, Rolo, and Castelo-Branco	Mary Jo Atkinson and colleagues
種類	Clinician-rated	Self-report
原典	Morgado, M., Rolo, S., & Castelo-Branco, M. (2012). Pharmacotherapy, 32(7), 652-660. (Original MRCI); Semla, T., & Beizer, J. (2018). American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society.	Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12.
別名	MRCI	TSQM
関連	4	4
概要	The Medication Regimen Complexity Index (MRCI) is a clinician-administered quantitative measure that objectively assesses the complexity of a patient's medication regimen based on the number of medications, frequency of dosing, and form of administration. Developed by Morgado, Rolo, and Castelo-Branco in 2012, the MRCI quantifies an important adherence barrier—the complexity of taking multiple medications with different schedules and administration routes. The MRCI is unique among adherence tools in that it measures an objective regimen characteristic (not patient behavior or belief), making it useful for deprescribing decisions, medication reconciliation, and identifying high-risk patients for non-adherence due to complexity.	The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies.